Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by subaru1on Sep 05, 2024 4:43pm

$0,06

is coming, bid size are lowering, Mr. Pidduck where is your $0,15, no news no development of any kind, just a very good pay check for him and his friends.
106
Discussion
Comment by Solid1on Sep 04, 2024 3:37pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ANDA - 505(b)(2)

 Source... where was the agreement reached? is that what you mean? --> https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=421213
91
Discussion
Comment by QContinuum1on Sep 04, 2024 1:59pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:ANDA - 505(b)(2)

The precedings are online.  Go look yourself. But if you want to save yourself some time, just the fact that they are occurring and some parties are settling should be proof enough. 
56
Discussion
Comment by QContinuum1on Sep 04, 2024 8:28am

RE:RE:RE:RE:RE:RE:RE:ANDA - 505(b)(2)

Again, the patent lawyers and judge overseeing the case seem to have a different opinion than you. 
42
Discussion
Comment by Solid1on Sep 04, 2024 4:24am

RE:RE:RE:RE:RE:RE:ANDA - 505(b)(2)

Jazz had exclusive rights to the active ingredient CBD for five years, this exclusivity expired in September 2023 (i.e. no patent). CBD cannot be patented. The patents that Jazz currently holds relate ...more  
88
Discussion
Comment by alleyesonmeon Sep 03, 2024 6:16pm

RE:RE:RE:RE:RE:ANDA - 505(b)(2)

Actually, litigation is only ongoing with one corp, the other 12 have settled with Jazz gaining marketing/selling approval on the condition of certain, unknown to the public milestones...and yes ...more  
94
Discussion
Comment by QContinuum1on Sep 03, 2024 3:17pm

RE:RE:RE:RE:RE:ANDA - 505(b)(2)

Apparently the patent office and the current litigation deem otherwise, so who really is the fool, lol Given you're a patent expert, just call up Strachan and tell him what you think, I'm ...more  
77
Discussion
Comment by Solid1on Sep 03, 2024 2:43pm

RE:RE:RE:RE:ANDA - 505(b)(2)

Epidiolex is just CBD. But by God you're a fool 
40
Discussion
Comment by QContinuum1on Sep 03, 2024 2:36pm

RE:RE:RE:ANDA - 505(b)(2)

ANDA has been confirmed by LABS on numerous calls that it is Epidiolex, period.  There is no reason to believe it is anything else and certainly no reason to smudge reality to make it something ...more  
70
Discussion
Comment by subaru1on Sep 03, 2024 11:43am

RE:RE:ANDA - 505(b)(2)

Fingers crossed since 3 years and still waiting that something happen. Already 2 months into the 3 qrt and no news about anything, with the few dollars that they put into the R&D it is not ...more  
72
Discussion
Comment by Solid1on Sep 03, 2024 9:13am

RE:RE:ANDA - 505(b)(2)

The lawsuits relate to a generic drug for the treatment of epilepsy. Jazz has lost important exclusive rights, which means that the same drug can be approved if it is a new treatment. For example ...more  
83
Discussion
Comment by QContinuum1on Sep 03, 2024 8:50am

RE:ANDA - 505(b)(2)

Eye on the ball people.  Epidiolex isn't going anywhere as long at the patent litigation is ongoing.  Guessing about what this or that may or may not mean is not meaningful.  Yes ...more  
70
Discussion
Comment by Solid1on Sep 03, 2024 4:32am

RE:RE:ANDA - 505(b)(2)

I didn't realise that GW Pharma had managed to do that. If Medipharm really does manage to develop a generic of Epidiolex, would they have exactly the same status?  https://www ...more  
64
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities